BIOLIFE SOLUTIONS INC's ticker is BLFS and the CUSIP is 09062W204. A total of 110 filers reported holding BIOLIFE SOLUTIONS INC in Q3 2020. The put-call ratio across all filers is 0.18 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,714,887 | -45.2% | 558,606 | -12.3% | 0.00% | -25.0% |
Q2 2023 | $14,070,002 | +32.5% | 636,602 | +30.4% | 0.00% | 0.0% |
Q1 2023 | $10,618,516 | +214849.7% | 488,275 | +79.9% | 0.00% | +300.0% |
Q4 2022 | $4,940 | -99.6% | 271,419 | +352.8% | 0.00% | 0.0% |
Q3 2022 | $1,363,000 | +640.8% | 59,937 | +348.8% | 0.00% | – |
Q2 2022 | $184,000 | -83.8% | 13,356 | -73.3% | 0.00% | – |
Q1 2022 | $1,138,000 | -67.1% | 50,076 | -46.0% | 0.00% | -100.0% |
Q4 2021 | $3,454,000 | -50.1% | 92,667 | -43.4% | 0.00% | -50.0% |
Q3 2021 | $6,928,000 | +102.1% | 163,713 | +112.5% | 0.00% | +100.0% |
Q2 2021 | $3,428,000 | +24.7% | 77,039 | +1.3% | 0.00% | 0.0% |
Q1 2021 | $2,750,000 | -12.4% | 76,042 | -3.3% | 0.00% | 0.0% |
Q4 2020 | $3,138,000 | +36.9% | 78,639 | -0.8% | 0.00% | 0.0% |
Q3 2020 | $2,293,000 | +105.1% | 79,237 | +15.7% | 0.00% | – |
Q2 2020 | $1,118,000 | +208.0% | 68,469 | +79.1% | 0.00% | – |
Q1 2020 | $363,000 | – | 38,239 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 7,566,292 | $171,982,000 | 7.71% |
Gagnon Advisors, LLC | 205,968 | $4,682,000 | 2.16% |
Ranger Investment Management | 1,300,407 | $29,558,000 | 1.87% |
GAGNON SECURITIES LLC | 379,506 | $8,626,000 | 1.41% |
Zweig-DiMenna Associates LLC | 376,550 | $8,559,000 | 1.14% |
Meros Investment Management, LP | 48,504 | $1,102,000 | 0.87% |
Mesirow Financial Investment Management, Inc. | 10,526 | $239,000 | 0.81% |
Penbrook Management LLC | 48,615 | $1,105,000 | 0.72% |
MOODY ALDRICH PARTNERS LLC | 220,680 | $5,016,000 | 0.70% |
GENEVA CAPITAL MANAGEMENT LLC | 1,456,656 | $33,110,000 | 0.64% |